RespireRx Pharmaceuticals Inc (fka RSPI)

[gershfinance]

Tony...don't get me wrong. My average cost is considerably higher than today's price, and I have a signicant position. I am very disappointed in the terms of the deal. I hope that the promised conference call will shed some light on the rationale.

But Stoll does ahve a ton of options, many of which are in the money. And the best I can tell from SEC filings, he has not executed and sold one share. His pain, from that perspective, is the same as ours.